Tobin Schilke - Chief Financial Officer at Crinetics Pharmaceuticals, Inc.

Issuer-level insider activity

Role: Chief Financial Officer
Issuer symbol: CRNX on Nasdaq
Entity type: Individual
SEC filing history: Open SEC filing history

Past-year transaction volume for Tobin Schilke in Crinetics Pharmaceuticals, Inc.

Buys

Open market

Shares
Avg price
Total value

Sells

Open market

Shares: -6,713
Avg price: $39.67
Total value: -$266,305

Net

Past year

Shares: -6,713
Share %: -100%
Total value: -$266,305

Reported holdings for Tobin Schilke in Crinetics Pharmaceuticals, Inc.

Form 4 holding Chief Financial Officer

Crinetics Pharmaceuticals, Inc.

Security class: Common Stock
Shares / value: 78,121
Estimated value: $3,099,060
Report date: 03 Mar 2026
Price: $39.67
Ownership: Direct

Form 4 holding Chief Financial Officer

Crinetics Pharmaceuticals, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 50,000
Estimated value
Report date: 23 Feb 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transaction history for Tobin Schilke in Crinetics Pharmaceuticals, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .